Product image of Methylfenidaat Xr Eg (Methylphenidate Hydrochloride) supplied by GNH India

Methylfenidaat Xr Eg

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Methylfenidaat Xr Eg (Methylphenidate Hydrochloride)

Methylphenidate, the active ingredient in Methylfenidaat Xr Eg, is a central nervous system stimulant presented as an oral formulation for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults.

GNH India supplies Methylfenidaat Xr Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable global distribution. Our supply chain adheres to stringent regulatory requirements to support patient care across diverse markets.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylfenidaat Xr Eg, a central nervous system stimulant, is used in conditions that involve dysregulation of dopamine and norepinephrine pathways.

  • Attention deficit hyperactivity disorder (ADHD): improves concentration, reduces hyperactivity and impulsivity.
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.
  • Behavioral symptoms in ADHD: lessens irritability and improves executive function.

How It Works

  • Methylphenidate inhibits the reuptake of dopamine and norepinephrine by blocking their respective transporters in the neuronal synapse. This increases the extracellular concentrations of these catecholamines, enhancing neurotransmission in brain regions that regulate attention, impulse control, and wakefulness, thereby producing its therapeutic effects in ADHD and narcolepsy.

Side Effects

Methylfenidaat Xr Eg may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced hunger leading to weight loss.
  • Headache: mild to moderate cranial pain.
  • Stomach pain: abdominal discomfort or nausea.
  • Irritability: increased emotional lability.
  • Weight loss: unintended reduction in body weight.

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, hypertension, or arrhythmia.
  • Psychosis: hallucinations or delusional thinking.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Priapism: prolonged painful erection.
  • Seizures: convulsive episodes.
  • Mood swings: emergence of severe depression or suicidal thoughts.

Precautions & Warnings

Before initiating therapy with Methylfenidaat Xr Eg, several safety considerations should be observed.

  • Cardiovascular assessment: evaluate heart history and blood pressure prior to use.
  • Psychiatric monitoring: watch for new or worsening anxiety, mood disorders, or psychotic symptoms.
  • Growth monitoring in children: regularly track height and weight during treatment.
  • Abuse potential: prescribe only when clinically indicated and monitor for misuse.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Methylfenidaat Xr Eg can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Antipsychotics (e.g., haloperidol): may reduce stimulant effectiveness.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonin syndrome risk.

  • Antihypertensive agents: may diminish blood pressure‑lowering effect.
  • Caffeine or other stimulants: additive central nervous system stimulation.
  • Alcohol: may exacerbate cardiovascular side effects.

Frequently Asked Questions

Methylfenidaat Xr Eg contains methylphenidate, a stimulant prescribed to manage attention deficit hyperactivity disorder (ADHD) and narcolepsy. It helps improve focus, reduce impulsivity, and lessen excessive daytime sleepiness in patients diagnosed with these conditions.

Methylphenidate blocks the reuptake of dopamine and norepinephrine at neuronal synapses, raising their levels in the brain. The increased catecholamine activity enhances signaling in pathways that control attention, impulse control, and wakefulness, which underlies its therapeutic effect.

The appropriate dose of Methylfenidaat Xr Eg is determined individually by a qualified prescriber based on the patient’s age, weight, clinical response, and tolerability. Dosage adjustments are made according to therapeutic goals and any observed side effects.

Safety data for methylphenidate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the prescribing clinician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methylfenidaat Xr Eg is a methylphenidate‑based stimulant, similar in action to other central nervous system stimulants such as amphetamine derivatives. Compared with non‑stimulant options, it generally offers faster onset of symptom control but may carry a higher risk of cardiovascular and psychiatric side effects, requiring careful monitoring.

Store the product at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, heat, and direct sunlight. Keep the container tightly closed and out of reach of children.

Methylfenidaat Xr Eg is taken orally, usually with a glass of water. It may be taken with or without food, but the prescriber may advise a consistent routine to maintain stable blood levels. Swallow tablets whole; do not crush or chew unless specifically instructed.

Serious risks include cardiovascular events such as hypertension or arrhythmia, psychiatric effects like psychosis or severe mood changes, and rare but severe allergic reactions. Patients should be monitored for chest pain, sudden mood shifts, or signs of an allergic response, and seek immediate medical attention if they occur.

Methylfenidaat Xr Eg is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, or patients with serious cardiovascular disorders, uncontrolled hypertension, hyperthyroidism, or a history of severe psychiatric illness unless the prescriber determines benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT